The influence of socioeconomic position on adjuvant treatment of stage III colon cancer: a systematic review and meta-analysis.

Acta Oncologica
A A KonradsenD L Nielsen

Abstract

Patients with colon cancer (CC) with low socioeconomic position (SEP) have a worse survival than patients with high SEP. We investigated the association between different socioeconomic indicators and the steps in the treatment trajectory leading to initiation of adjuvant chemotherapy (ACT) for patients with stage III CC. A systematic review and meta-analyses were conducted in accordance with the MOOSE checklist. MEDLINE and EMBASE were searched for eligible studies. Meta-analyses were performed on the separate socioeconomic indicators with the random-effects model. The heterogeneity across studies was assessed by the Q and the I 2 statistic. In total, 27 observational studies were included. SEP was measured by insurance, income, poverty, employment, education, or an index on an area or individual level. SEP, regardless of indicator, was negatively associated with the steps in the treatment trajectory leading to initiation of ACT among patients with resected stage III CC. The meta-analyses showed that patients with low SEP had a significantly lower odds of receiving ACT and increased odds of delayed treatment start, whereas SEP had no impact on the choice of therapy: combination or single-agent therapy. SEP was associated with l...Continue Reading

References

Feb 8, 1990·The New England Journal of Medicine·C G MoertelJ H Glick
Oct 24, 1997·Cancer·C T SchrijversJ P Mackenbach
Jun 8, 2001·Journal of the National Cancer Institute·D SchragC B Begg
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Z AyanianWilliam E Wright
Apr 7, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharlene GillRichard M Goldberg
Apr 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V E P P LemmensJ W W Coebergh
Aug 18, 2005·Journal of the National Cancer Institute·Laura-Mae BaldwinStephen H Taplin
Sep 7, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L M WoodsM P Coleman
Dec 20, 2005·Journal of Epidemiology and Community Health·Bruna GalobardesGeorge Davey Smith
Feb 14, 2006·Diseases of the Colon and Rectum·Marcia L McGoryClifford Y Ko
Feb 8, 2007·British Medical Bulletin·Bruna GalobardesGeorge Davey Smith
Dec 18, 2007·Lancet·UNKNOWN Quasar Collaborative GroupDavid J Kerr
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thierry AndréAimery de Gramont
Nov 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L N van SteenbergenV E P P Lemmens
Jun 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mieke J AartsJan Willem W Coebergh
Jan 18, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nina Cavalli-BjörkmanBengt Glimelius
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel G HallerHans-Joachim Schmoll
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Greg YothersNorman Wolmark
Mar 14, 2012·International Journal for Equity in Health·Evelyn VerlindeSara Willems
Sep 27, 2012·Archives of Gynecology and Obstetrics·Leslie Williams-BrennanLawrence Paszat
May 18, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·L G M van der GeestUNKNOWN All Nine Hospitals in the Leiden Region of the Comprehensive Cancer Centre The Netherlands
Oct 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R LabiancaUNKNOWN ESMO Guidelines Working Group
Oct 31, 2013·Annals of Surgery·Ryan P MerkowKarl Y Bilimoria
Jul 8, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caitlin C MurphyAnn M Geiger
Sep 4, 2015·Therapeutic Advances in Medical Oncology·Smrity UpadhyayPeter T Silberstein
Jan 7, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·Christopher M BoothWilliam J Mackillop
Feb 19, 2016·CA: a Cancer Journal for Clinicians·Diana SarfatiChristopher Jackson
Mar 18, 2016·Ulusal cerrahi dergisi·Bahattin BayarHakan Kulaçoğlu
Jun 1, 2016·International Journal of Cancer. Journal International Du Cancer·Susanne SingerHelge Danker
Jun 11, 2016·Journal of Gastrointestinal Oncology·Alica S SparlingKristie L Foley
Nov 10, 2017·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Whitney GuerreroDavid Shibata

❮ Previous
Next ❯

Citations

Jun 19, 2021·Annals of Surgical Oncology·Fabian M JohnstonJohn H Stewart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.